Conjunts de dades de producció científica> Bioquímica i Biotecnologia

Plasma fatty acid levels at baseline and 1-year changes according to the intervention groups.A

  • Dades identificatives

    Identificador: PC:4089
    Autors:
    Salas-Salvadó, Jordi
    Resum:
    MetS, Metabolic Syndrome; BMI, body mass index; CHD, coronary heart disease; WC, waist circumference; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; BP, blood pressure. A. Values are expressed as mean ± SD or percentage of participants. B. p value for comparison between groups calculated by one-factor ANOVA for continuous variables or χ2 test for categorical variables. C. BMI≥25 kg/m2. D. Systolic BP≥140 mmHg or diastolic BP≥90 mmHg or antihypertensive medication. E. LDL cholesterol ≥160 mg/dL or lipid-lowering therapy; HDL cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women. F. Definite myocardial infarction or sudden death before 55 years in male first-degree relatives or before 65 years in female first-degree relatives. G. The metabolic syndrome components are defined according to the IDF, NHLBI, AHA, WHF, IAC, and IASO recent criteria.
  • Altres:

    Matèria: Biologia
    Drets d'accés: info:eu-repo/semantics/openAccess
    Identificador del investigador: 0000-0003-2700-7459
    Publicat per (editora): Universitat Rovira i Virgili (URV)
    Publicacions relacionades: Mayneris-Perxachs, J., Sala-Vila, A., Chisaguano, M., Castellote, A. I., Estruch, R., Covas, M. I., Fitó, M., Salas-Salvadó, J., Martínez-González, M. A., Lamuela-Raventós, R., Ros, E., López-Sabater, M. C., & for PREDIMED Study Investigators. (2014). Effects of 1-year intervention with a mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk. PLoS ONE, 9(3), e85202. https://doi.org/10.1371/journal.pone.0085202
    Resum: MetS, Metabolic Syndrome; BMI, body mass index; CHD, coronary heart disease; WC, waist circumference; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; BP, blood pressure. A. Values are expressed as mean ± SD or percentage of participants. B. p value for comparison between groups calculated by one-factor ANOVA for continuous variables or χ2 test for categorical variables. C. BMI≥25 kg/m2. D. Systolic BP≥140 mmHg or diastolic BP≥90 mmHg or antihypertensive medication. E. LDL cholesterol ≥160 mg/dL or lipid-lowering therapy; HDL cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women. F. Definite myocardial infarction or sudden death before 55 years in male first-degree relatives or before 65 years in female first-degree relatives. G. The metabolic syndrome components are defined according to the IDF, NHLBI, AHA, WHF, IAC, and IASO recent criteria.
    Departament: Bioquímica i Biotecnologia
    DOI: 10.1371/journal.pone.0085202.t002
    Tipus de document: info:eu-repo/semantics/other
    DOI de la publicació relacionada: Baseline characteristics of participants completing 1-year intervention.A
    Data alta repositori: 2014-03-20
    Autor: Salas-Salvadó, Jordi
    Paraules clau: Biochemistry, lipids, Fatty acids, Lipid metabolism, metabolism, nutrition, cardiology, Cardiovascular, harmacology, Clinical medicine, clinical trials, epidemiology, Biomarker epidemiology, Cardiovascular disease epidemiology, Environmental epidemiology, Metabolic disorders, Public and occupational health, Behavioral and social aspects of health, research design, Clinical research design, fatty, baseline, 1-year
    Grup de recerca: Alimentación, Nutrición, Crecimiento y Salud Mental
    Any de publicació de la dataset: 2014
    Títol del conjunt de dades: Plasma fatty acid levels at baseline and 1-year changes according to the intervention groups.A
  • Paraules clau:

    Biologia
    Biochemistry, lipids, Fatty acids, Lipid metabolism, metabolism, nutrition, cardiology, Cardiovascular, harmacology, Clinical medicine, clinical trials, epidemiology, Biomarker epidemiology, Cardiovascular disease epidemiology, Environmental epidemiology, Metabolic disorders, Public and occupational health, Behavioral and social aspects of health, research design, Clinical research design, fatty, baseline, 1-year
  • Documents:

  • Cerca a google

    Search to google scholar